BlackRock Group’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.16M	Sell	141,630 -2,766	-2%	-$84.3K	﹤0.01%	1293
2016 Q3	$4.18M	Sell	144,396 -47,673	-25%	-$1.33M	﹤0.01%	1193
2016 Q2	$4.97M	Buy	192,069 +11,288	+6%	+$300K	﹤0.01%	1097
2016 Q1	$4.48M	Sell	180,781 -2,294	-1%	-$63K	﹤0.01%	1124
2015 Q4	$6.45M	Sell	183,075 -5,544	-3%	-$148K	﹤0.01%	1033
2015 Q3	$3.99M	Buy	188,619 +1,408	+0.8%	+$36.3K	﹤0.01%	1175
2015 Q2	$5.2M	Buy	187,211 +28,964	+18%	+$817K	﹤0.01%	1134
2015 Q1	$4.83M	Buy	158,247 +4,600	+3%	+$146K	﹤0.01%	1134
2014 Q4	$4.91M	Buy	153,647 +152,600	+14,575%	+$4.97M	﹤0.01%	1133
2014 Q3	$30K	Hold	1,047	–	–	﹤0.01%	2739
2014 Q2	$29K	Sell	1,047 -20,614	-95%	-$549K	﹤0.01%	2750
2014 Q1	$571K	Hold	21,661	–	–	﹤0.01%	2200
2013 Q4	$634K	Hold	21,661	–	–	﹤0.01%	2148
2013 Q3	$662K	Hold	21,661	–	–	﹤0.01%	2114
2013 Q2	$687K	Buy	+21,661	New	+$711K	﹤0.01%	1956

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock Group's GHDX Position: Q4 2016 in Review

BlackRock Group reduced its Genomic Health, Inc. (GHDX) stake by 1.9% in Q4 2016, selling an estimated $84.3K and leaving 141,630 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

BlackRock Group first reported a position in GHDX in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.45M in Q4 2015. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Group held 141,630 shares of Genomic Health, Inc. worth $4.16M as of Q4 2016.
BlackRock Group sold 2,766 Genomic Health, Inc. shares in Q4 2016, an estimated $84.3K.
Genomic Health, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1293 holding.
BlackRock Group first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Group's Genomic Health, Inc. position peaked at $6.45M in Q4 2015.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.